Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group

Circulation. 2002 Oct 1;106(14):1867-73. doi: 10.1161/01.cir.0000033485.20594.6f.
No abstract available

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiography / standards
  • Animals
  • Cell Culture Techniques
  • Coated Materials, Biocompatible / standards
  • Consensus Development Conferences as Topic
  • Coronary Artery Disease / pathology
  • Coronary Artery Disease / therapy
  • Delayed-Action Preparations* / adverse effects
  • Delayed-Action Preparations* / pharmacokinetics
  • Delayed-Action Preparations* / standards
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical / standards*
  • Drug Implants* / adverse effects
  • Drug Implants* / pharmacokinetics
  • Drug Implants* / standards
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / prevention & control
  • Humans
  • Iliac Artery
  • Platelet Aggregation Inhibitors / therapeutic use
  • Rabbits
  • Research Design / standards*
  • Stents* / adverse effects
  • Stents* / classification
  • Stents* / standards
  • Swine
  • Thrombosis / prevention & control
  • Tissue Fixation

Substances

  • Coated Materials, Biocompatible
  • Delayed-Action Preparations
  • Drug Implants
  • Platelet Aggregation Inhibitors